[EN] NOVEL DXR INHIBITORS FOR ANTIMICROBIAL THERAPY<br/>[FR] NOUVEAUX INHIBITEURS DE DXR POUR THÉRAPIE ANTIMICROBIENNE
申请人:BAYLOR COLLEGE MEDICINE
公开号:WO2011046920A1
公开(公告)日:2011-04-21
The present invention generally concerns particular methods and compositions for antimicrobial therapy. In particuarl embodiments, the compositions target DXR. In specific embodiments, the compositions are electron-deficient heterocyclic rings.
Synthesis, Structural Aspects and Catalytic Performance of a Tetrahedral Cobalt Phosphonate Framework
作者:Rupam Sen、Debraj Saha、Dasarath Mal、Paula Brandão、Guillaume Rogez、Zhi Lin
DOI:10.1002/ejic.201300639
日期:2013.10
the Schlafli symbol 315.422.58. The magnetic measurement reveals the tetrahedral coordinated CoII ion. The compound is highly active towards epoxidation in the presence of air and IBA (isobutyraldehyde). It catalyses almost all types of olefinic substrates with equal efficiency. The compound is highly stable thermally (370 °C) and under the reaction conditions as well. After the reaction it can be
The present invention generally concerns particular methods and compositions for antimicrobial therapy. In particular embodiments, the compositions target DXR. In specific embodiments, the compositions are electron-deficient heterocyclic rings.
METHOD TO IDENTIFY COMPOUNDS ABLE TO BIND TO THE ROSSMANN FOLD OF C-TERMINAL-BINDING PROTEINS, IDENTIFIED COMPOUNDS AND MEDICAL USES THEREOF
申请人:CONSIGLIO NAZIONALE DELLE RICERCHE
公开号:US20170003275A1
公开(公告)日:2017-01-05
The invention refers to a method for identifying an anti-tumoral and/or anti-proliferative and/or an inhibitor of the fission machinery involved in mitotic Golgi partitioning and/or a molecule modulator of CtBP corepressor activity by testing their affinity binding for the Rossmann fold of C-terminal-binding proteins (CtBPs); to said identified molecules and to the use thereof as anti-proliferative and/or anti tumoral agents.